INTERFERON BETA-1B IN THE TREATMENT OF MULTIPLE-SCLEROSIS - FINAL OUTCOME OF THE RANDOMIZED CONTROLLED TRIAL by Duquette, P, Despault, L, Knobler, R, Lublin, F, Kelley, L, Francis, G, Freedman, M, Lapierre, Y, Greenstein, J, Mishra, B, Delillio, N, Whitaker, J, Layton, B, Sibley, W, Laguna, J, Krikawa, J, Paty, D, Oger, J, Kastrukoff, L, Morrison, W, Nelson, J, Goodin, D, Massa, S, Gutteridge, E, Arnason, B

Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis by Petkau, A, White, R, Ebers, G, Reder, A, Sibley, W, Lublin, F, Paty, D, Duquette, P, Girard, M, Despault, L, DuBois, R, Knobler, R, Kelley, L, Francis, G, Lapierre, Y, Antel, J, Freedman, M, Hum, S, Greenstein, J, Mishra, B, Muldoon, J, Whitaker, J, Evans, B, Layton, B, Laguna, J